Fundraising FoxTerremoto Biosciences
South San Francisco, US · Founded 2022 · 5 known investors
Find your way into Terremoto Biosciences
Sign up to see every warm intro you have to Terremoto Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Terremoto Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry. It pursues both best-in-class treatments against known drug targets and first-in-class medicines against previously undruggable targets.
Founders & leadership
Board
Investors · 5
How we know: funding news · Not right? Tell us
How we know: OrbiMed's portfolio page · a partner's Signal profile · press coverage · funding news · Not right? Tell us
How we know: RA Capital's portfolio page · press coverage · funding news · Not right? Tell us
How we know: press coverage · funding news · Not right? Tell us
How we know: a partner's Signal profile · board seat on SEC Form D · press coverage · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$40.7M disclosed across 1 of 2 rounds · 2023–2026
- Undisclosed amountseries BNov 2023Source ↗
▶$40.7MraisedApr 2026 · 14 investors · BiotechnologyRule 506(b)
- Michael GollerDirector
- Grace LuExecutive Officer
- James ChristensenExecutive Officer, Director
- Reid HuberDirector
- Peter ThompsonDirector
- Daniel O'ConnellDirector
- Charles BaumExecutive Officer, Director
- Offering amount
- $108.6M
- Amount sold
- $40.7M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Terremotobio went on to found or lead other companies.
In the news
Frequently asked questions
- What does Terremoto Biosciences do?
- Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry. It pursues both best-in-class treatments against known drug targets and first-in-class medicines against previously undruggable targets.
- Who are Terremoto Biosciences's investors?
- Terremoto Biosciences's investors include EcoR1 Capital, OrbiMed, RA Capital, Novo Holdings, Third Rock Ventures.
- How much funding has Terremoto Biosciences raised?
- Terremoto Biosciences has disclosed $40.7M raised across 1 of its 2 known rounds.
- Where is Terremoto Biosciences headquartered?
- Terremoto Biosciences is headquartered in South San Francisco, US.